Actionable genetic landscape and dynamics in circulating DNA from 12,827 patients with metastatic breast cancer

By afschroeder • October 23, 2026

Leshchiner I, Medford AJ, Cha J, Kiedrowski LA, Niemierko A, Keenan JC, Dai CS, Spring LM, Moy B, Wander SA, Vidula N, Isakoff SJ, Juric D, Miller M, Davis AA, Gerratana L, Shah A, Park BH, Brufsky A, O'Shaughnessy J, Nagy RJ, Ellisen LW, Cristofanilli M, Bardia A, Getz G. Actionable genetic landscape and dynamics in circulating DNA from 12,827 patients with metastatic breast cancer. Nat Commun. 2026 Sep 22;17(1):11023. doi: 10.1038/s41467-026-75976-9. PMID: 42907427.

Tags: Hematology/Oncology, Publications

Carboplatin Plus Mirvetuximab Soravtansine In Platinum-Sensitive Ovarian Cancer: A Phase 2 Nonrandomized Clinical Trial

Konecny GE, Lim PC, Santin AD, Gilbert L, Alvarez Secord A, Bessette P, Matulonis UA, Sen J, Hong J, Lytle GE, Bako E, Spunt SL,[...]

Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer. Reply

O'Reilly EM, Wolpin BM, Wainberg ZA. Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer. Reply. N Engl J Med. 2026 Oct 22;395(16):1662. doi: 10.1056/NEJMc2611022. PMID: 42906097.

Pembrolizumab plus gemcitabine and cisplatin for advanced biliary tract cancer: longer-term follow-up from the randomised, double-blind, placebo-controlled, phase 3 KEYNOTE-966 trial

Ueno M, Yoo C, Ren Z, Furuse J, Kelley RK, Chan SL, Edeline J, Klümpen HJ, Yau T, Verslype C, Ozaka M, Bouattour M, Park[...]